Anti-ITCH monoclonal antibody

Pre-made anti-ITCH monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ITCH/ITCH products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T81240-Ab-1/ GM-Tg-hg-T81240-Ab-2Anti-Human ITCH monoclonal antibodyHuman
GM-Tg-rg-T81240-Ab-1/ GM-Tg-rg-T81240-Ab-2Anti-Rat ITCH monoclonal antibodyRat
GM-Tg-mg-T81240-Ab-1/ GM-Tg-mg-T81240-Ab-2Anti-Mouse ITCH monoclonal antibodyMouse
GM-Tg-cynog-T81240-Ab-1/ GM-Tg-cynog-T81240-Ab-2Anti-Cynomolgus/ Rhesus macaque ITCH monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T81240-Ab-1/ GM-Tg-felg-T81240-Ab-2Anti-Feline ITCH monoclonal antibodyFeline
GM-Tg-cang-T81240-Ab-1/ GM-Tg-cang-T81240-Ab-2Anti-Canine ITCH monoclonal antibodyCanine
GM-Tg-bovg-T81240-Ab-1/ GM-Tg-bovg-T81240-Ab-2Anti-Bovine ITCH monoclonal antibodyBovine
GM-Tg-equg-T81240-Ab-1/ GM-Tg-equg-T81240-Ab-2Anti-Equine ITCH monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T81240-Ab-1/ GM-Tg-hg-T81240-Ab-2; GM-Tg-rg-T81240-Ab-1/ GM-Tg-rg-T81240-Ab-2;
GM-Tg-mg-T81240-Ab-1/ GM-Tg-mg-T81240-Ab-2; GM-Tg-cynog-T81240-Ab-1/ GM-Tg-cynog-T81240-Ab-2;
GM-Tg-felg-T81240-Ab-1/ GM-Tg-felg-T81240-Ab-2; GM-Tg-cang-T81240-Ab-1/ GM-Tg-cang-T81240-Ab-2;
GM-Tg-bovg-T81240-Ab-1/ GM-Tg-bovg-T81240-Ab-2; GM-Tg-equg-T81240-Ab-1/ GM-Tg-equg-T81240-Ab-2
Products NameAnti-ITCH monoclonal antibody
Formatmab
Target NameITCH
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ITCH monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T81240-Ag-1Recombinant multi-species ITCH/ ADMFD/ AIF4 protein
    ORF Viral VectorvGMLV000051human ITCH Lentivirus particle
    ORF Viral VectorpGMLV000051human ITCH Lentivirus plasmid
    ORF Viral VectorpGMLPm003580mouse Itch Lentivirus plasmid
    ORF Viral VectorvGMLPm003580mouse Itch Lentivirus particle


    Target information

    Target IDGM-T81240
    Target NameITCH
    Gene ID83737,16396,311567,707640,477199,101086133,508431,100069340
    Gene Symbol and Synonyms6720481N21Rik,8030492O04Rik,A130065M08,ADMFD,AIF4,AIP4,C230047C07Rik,ITCH,NAPP1
    Uniprot AccessionQ96J02
    Uniprot Entry NameITCH_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000078747
    Target ClassificationTumor-associated antigen (TAA)

    The target: ITCH, gene name: ITCH, also named as ADMFD, AIF4, AIP4, NAPP1. This gene encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases. HECT domain E3 ubiquitin ligases transfer ubiquitin from E2 ubiquitin-conjugating enzymes to protein substrates, thus targeting specific proteins for lysosomal degradation. The encoded protein plays a role in multiple cellular processes including erythroid and lymphoid cell differentiation and the regulation of immune responses. Mutations in this gene are a cause of syndromic multisystem autoimmune disease. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.